Skip to content

A Single-center Clinical Observational Study on the Topical Application of Yanling Zhitong Formula Essential Oil for Cancer Pain

A Single-center Clinical Observational Study on the Topical Application of Yanling Zhitong Formula Essential Oil for Cancer Pain

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000929
Enrollment
Unknown
Registered
2026-04-09
Start date
2026-04-30
Completion date
Unknown
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Pain

Interventions

Therapy group:Yanling Zhitong Fang + Three-step Pain Relief

Sponsors

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, No. 725, Wanping South Road, Xuhui District, Shanghai, China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1) Patients with cytologically or pathologically diagnosed malignant tumors, experiencing cancer pain at clearly defined sites. 2) Candidates suitable for topical medication, with no history of drug or food allergies. 3) Age =18 years and =85 years, with good compliance. 4) Expected survival period >12 weeks. 5) No dysfunction of major organs in the subjects, with normal blood counts, and normal liver, kidney, and cardiac functions. 6) Capable of comprehending the study details and providing signed informed consent.

Exclusion criteria

Exclusion criteria: 1) Patients without a clear pathological diagnosis. 2) Patients currently undergoing or having completed radiotherapy/chemotherapy within less than 3–4 weeks. 3) Patients with an expected survival period of less than 3 months. 4) Patients complicated with severe diseases of the heart, liver, kidneys, hematopoietic system, or other major organs. 5) Patients with pregnancy confirmed by HCG testing or those who are lactating. 6) Patients with a history of psychiatric disorders that are difficult to manage.

Design outcomes

Primary

MeasureTime frame
NRS pain score;

Secondary

MeasureTime frame
Equivalent Morphine Consumption;Security indicators;

Countries

China

Contacts

Public ContactChangsheng Dong

Longhua hospital, Shanghai University of Traditional Chinese Medicine

dongchangsheng2010@163.com+86 188 0161 5930

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: May 1, 2026